Effects of clodronate on early alveolar bone remodeling and root resorption related to orthodontic forces: A histomorphometric analysis

American Journal of Orthodontics and Dentofacial Orthopedics

Volumn 138, Issue 5, 2010, Pages 548.e1-548.e8

  Choi, Josefina ^a   Baek, Seung Hak ^a   Lee, Jae Il ^a   Chang, Young Il ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALIZARIN; ANTHRAQUINONE DERIVATIVE; BONE DENSITY CONSERVATION AGENT; CALCEIN; CLODRONIC ACID; DENTAL ALLOY; DIAGNOSTIC AGENT; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; NICKEL; TETRACYCLINE; TITANIUM; TITANIUM NICKELIDE;

ANIMAL; ARTICLE; BONE MINERALIZATION; BONE REMODELING; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; INCISOR; INSTRUMENTATION; JAW; MALE; MECHANICAL STRESS; METHODOLOGY; MOLAR TOOTH; ORTHODONTIC DEVICE; PATHOLOGY; PERIODONTAL DISEASE; RAT; TIME; TOOTH DISEASE; WISTAR RAT;

ALVEOLAR PROCESS; ANIMALS; ANTHRAQUINONES; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; CLODRONIC ACID; DENTAL ALLOYS; FEMALE; FLUORESCEINS; FLUORESCENT DYES; INCISOR; MALE; MOLAR; NICKEL; ORTHODONTIC WIRES; RATS; RATS, WISTAR; ROOT RESORPTION; STRESS, MECHANICAL; TETRACYCLINE; TIME FACTORS; TITANIUM; TOOTH MOVEMENT;

EID: 78149449903     PISSN: 08895406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajodo.2010.01.031     Document Type: Article

References (39)

1. E.R. Van Beek, C.W. Löwik, and S.E. Papapoulos Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonate on osteoclast precursors Bone 30 2002 64 70
2. G.L. Plosker, and K.L. Goa Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease Drugs 47 1994 945 982
3. A. Bonabello, M.R. Galmozzi, R. Canaparo, L. Serpe, and G.P. Zara Long-term analgesic effect of clodronate in rodents Bone 33 2003 567 574
4. G.A. Rodan, and H.A. Fleisch Bisphosphonates: mechanisms of action J Clin Invest 97 1996 2692 2696
5. P.J. Meunier, P.D. Delmas, R. Eastell, M.R. McClung, S. Papapoulos, and R. Rizzoli Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines Clin Ther 21 1999 1025 1044
6. J.A. Kanis, T. Powles, A.H. Paterson, E.V. McCloskey, and S. Ashley Clodronate decreases the frequency of skeletal metastases in women with breast cancer Bone 19 1996 663 667
7. P. Filipponi, S. Cristallini, E. Rizzello, G. Policani, L. Fedeli, and F. Gregorio Cyclical intravenous clodronate in postmenopausal osteoporosis: results of a long-term clinical trial Bone 18 1996 179 184
8. J. Reginster, H.W. Minne, O.H. Sorensen, M. Hooper, C. Roux, M.L. Brandi Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis Vertebral Efficacy with Risedronate Therapy (VERT) Study Group Osteoporos Int 11 2000 83 91
9. E.V. McCloskey, J.A. Dunn, J.A. Kanis, I.C. MacLennan, and M.T. Drayson Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myeloma Br J Haematol 113 2001 1035 1043
10. A.M. Flanagan, and T.J. Chambers Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone Calcif Tissue Int 49 1991 407 415
11. D. Horie, M. Takahashi, K. Aoki, and K. Ohya Clodronate stimulates bone formation as well as inhibits bone resorption and increases bone mineral density in rats fed a low-calcium diet J Med Dent Sci 50 2003 121 132
12. H. Adachi, K. Igarashi, H. Mitani, and H. Shinoda Effects of topical administration of a bisphosphonate (risedronate) on orthodontic tooth movements in rats J Dent Res 73 1994 1478 1486
13. K. Igarashi, H. Mitani, H. Adachi, and H. Shinoda Anchorage and retentive effects of a bisphosphonate (AHBuBP) on tooth movements in rats Am J Orthod Dentofacial Orthop 106 1994 279 289
14. K. Igarashi, H. Adachi, H. Mitani, and H. Shinoda Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats J Dent Res 75 1996 1644 1649
15. L. Liu, K. Igarashi, N. Haruyama, S. Saeki, H. Shinoda, and H. Mitani Effects of local administration of clodronate on orthodontic tooth movement and root resorption in rats Eur J Orthod 26 2004 469 473
16. M.J. Rogers, S. Gordon, H.L. Benford, F.P. Coxon, S.P. Luckman, and J. Mönkkönen Cellular and molecular mechanisms of action of bisphosphonates Cancer 88 2000 2961 2978
17. J.C. Frith, J. Mönkkönen, S. Auriola, H. Mönkkönen, and M.J. Rogers The molecular mechanism of action of the antiresorptive and anti-inflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis Arthritis Rheum 44 2001 2201 2210
18. B.J. Leiker, R.S. Nanda, G.F. Currier, R.I. Howes, and P.K. Sinha The effects of exogenous prostaglandins on orthodontic tooth movement in rats Am J Orthod Dentofacial Orthop 108 1995 380 388
19. W.J. Rody Jr., G.J. King, and G. Gu Osteoclast recruitment to sites of compression in orthodontic tooth movement Am J Orthod Dentofacial Orthop 120 2001 477 489 (Pubitemid 33608885)
20. C. Capparelli, S. Morony, K. Warmington, S. Adamu, D. Lacey, and C.R. Dunstan Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats J Bone Miner Res 18 2003 852 858
21. R. Oyonarte, R.M. Pilliar, D. Deporter, and D.G. Woodside Peri-implant bone response to orthodontic loading: part 2. Implant surface geometry and its effect on regional bone remodeling Am J Orthod Dentofacial Orthop 128 2005 182 189 (Pubitemid 41105396)
22. K. Donath, and G. Breuner A method for the study of undecalcified bones and teeth with attached soft tissues. The Säge-Schliff (sawing and grinding) technique J Oral Pathol 11 1982 318 326
23. M. Seifi, B. Eslami, and A.S. Saffar The effect of prostaglandin E2 and calcium gluconate on orthodontic tooth movement and root resorption in rats Eur J Orthod 25 2003 199 204
24. A.M. Parfitt Bone histomorphometry: standardization of nomenclature, symbols and units (summary of proposed system) Bone 9 1988 67 69
25. R.M. Pilliar Overview of surface variability of metallic endosseous dental implants: textured and porous surface-structured designs Implant Dent 7 1998 305 314
26. N.F. Talic, C. Evans, and A.M. Zaki Inhibition of orthodontically induced root resorption with echistatin, an RGD-containing peptide Am J Orthod Dentofacial Orthop 129 2006 252 260
27. C. Verna, M. Dalstra, and B. Melsen Bone turnover rate in rats does not influence root resorption induced by orthodontic treatment Eur J Orthod 25 2003 359 363
28. D. Pavlin, E.S. Goldman, J. Gluhak-Heinrich, M. Magness, and R. Zadro Orthodontically stressed periodontium of transgenic mouse as a model for studying mechanical response in bone: the effect on the number of osteoblasts Clin Orthod Res 3 2000 55 66
29. A. Keles, B. Grunes, C. Difuria, E. Gagari, V. Srinivasan, and M.A. Darendeliler Inhibition of tooth movement by osteoprotegerin vs. pamidronate under conditions of constant orthodontic force Eur J Oral Sci 115 2007 131 136
30. G.J. King, S.D. Keeling, and T.J. Wronski Histomorphometric study of alveolar bone turnover in orthodontic tooth movement Bone 12 1991 401 409
31. J.M. Halasy-Nagy, G.A. Rodan, and A.A. Reszka Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis Bone 29 2001 553 559
32. L. Liu, K. Igarashi, H. Kanzaki, M. Chiba, H. Shinoda, and H. Mitani Clodronate inhibits PGE(2) production in compressed periodontal ligament cells J Dent Res 85 2006 757 760
33. J.W. Graham Bisphosphonates and orthodontics: clinical implications J Clin Orthod 40 2006 425 428
34. J.J. Zahrowski Bisphosphonate treatment: an orthodontic concern calling for a proactive approach Am J Orthod Dentofacial Orthop 131 2007 311 320
35. J.J. Zahrowski Optimizing orthodontic treatment in patients taking bisphosphonates for osteoporosis Am J Orthod Dentofacial Orthop 135 2009 361 374
36. E. McCloskey, P. Selby, M. Davies, J. Robinson, R.M. Francis, and J. Adams Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study J Bone Miner Res 19 2004 728 736
37. S. Giannini, A. D'Angelo, L. Malvasi, R. Castrignano, T. Pati, and R. Tronca Effects of one-year cyclical treatment with clodronate on postmenopausal bone loss Bone 14 1993 137 141
38. J.R. Berenson, L.S. Rosen, A. Howell, L. Porter, R.E. Coleman, and W. Morley Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases Cancer 91 2001 1191 1200
39. I.R. Reid, J.P. Brown, P. Burckhardt, Z. Horowitz, P. Richardson, and U. Trechsel Intravenous zoledronic acid in postmenopausal women with low bone mineral density N Eng J Med 346 2002 653 661 (Pubitemid 34815869)